<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03292159</url>
  </required_header>
  <id_info>
    <org_study_id>2017P000129</org_study_id>
    <nct_id>NCT03292159</nct_id>
  </id_info>
  <brief_title>Transcutaneous Vagus Nerve Stimulation for Motor Recovery After Stroke</brief_title>
  <official_title>Safety and Effectiveness of Transcutaneous Vagus Nerve Stimulation Therapy to Improve Motor Recovery After Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dana Foundation, Spaulding Rehabilitation Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the safety and effectiveness of Respiratory-gated Auricular Vagal&#xD;
      Afferent Nerve Stimulation (RAVANS) for improving motor recovery after stroke. Subacute&#xD;
      stroke patients will receive RAVANS or sham stimulation concurrent with arm motor training&#xD;
      during 10 intervention sessions occurring daily for 30 minutes over 2 weeks. The safety and&#xD;
      improvements in arm motor function after the intervention will be compared in patients&#xD;
      receiving RAVANS to those receiving sham stimulation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will evaluate the safety, feasibility and effectiveness of Respiratory-gated&#xD;
      Auricular Vagal Afferent Nerve Stimulation (RAVANS) for improving motor recovery after&#xD;
      stroke. Subacute stroke patients will be randomized to RAVANS or sham stimulation groups.&#xD;
      Patients will receive RAVANS or sham stimulation concurrent with arm motor training during 10&#xD;
      sessions occurring daily for 30 minutes over 2 weeks. Safety will be compared in patients&#xD;
      receiving RAVANS to those receiving sham stimulation. Feasibility will be evaluated by&#xD;
      recruitment into the study and retention of enrolled patients. Changes in arm motor function&#xD;
      will be compared between RAVANS and sham stimulation groups from baseline to immediately&#xD;
      after the intervention period and to function at 3-months after stroke.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    funding not continued&#xD;
  </why_stopped>
  <start_date type="Actual">May 17, 2018</start_date>
  <completion_date type="Actual">November 20, 2018</completion_date>
  <primary_completion_date type="Actual">November 20, 2018</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Upper extremity motor impairment</measure>
    <time_frame>Baseline to just after 10 intervention sessions, and baseline to 3 months post-stroke</time_frame>
    <description>Change in upper extremity subtest of Fugl Meyer Assessment (FMA-UE) score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Upper extremity motor function</measure>
    <time_frame>Baseline to just after 10 intervention sessions, and baseline to 3 months post-stroke</time_frame>
    <description>Change in Action Research Arm Test (ARAT) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip force control</measure>
    <time_frame>Baseline to just after 10 intervention sessions, and baseline to 3 months post-stroke</time_frame>
    <description>Change in accuracy, variability and temporal structure of performance on a grip force control task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Upper extremity disability</measure>
    <time_frame>Baseline to 3 months post-stroke</time_frame>
    <description>Change in hand subtest of Stroke Impact Scale (SIS-hand) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mood state, anxiety and depression</measure>
    <time_frame>Baseline to 3 months post-stroke</time_frame>
    <description>Change in Hospital Anxiety and Depression Scale (HADS) scores</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Stroke</condition>
  <condition>Upper Extremity Paresis</condition>
  <arm_group>
    <arm_group_label>RAVANS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active RAVANS concurrent with arm motor training</intervention_name>
    <description>Patient receives non-painful, sensory-level stimulation to the skin of left outer ear, where nerve endings of the auricular branch of the vagus nerve reside, while participating in arm motor training</description>
    <arm_group_label>RAVANS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Inactive RAVANS concurrent with arm motor training</intervention_name>
    <description>Patient does not receive stimulation delivered to the skin of left outer ear while participating in arm motor training</description>
    <arm_group_label>Sham stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Supratentorial ischemic or hemorrhagic stroke incurred 4-30 days prior;&#xD;
&#xD;
          -  Contralesional UL motor impairment defined by NIHSS item 5 score 1 or 2 (scale 0-4);&#xD;
&#xD;
          -  Age â‰¥ 18;&#xD;
&#xD;
          -  Able to provide written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Implanted electronic device (e.g., pacemaker, neurostimulator);&#xD;
&#xD;
          -  Pregnancy;&#xD;
&#xD;
          -  Major psychiatric or medical condition that could interfere with study participation;&#xD;
&#xD;
          -  Medical condition affecting left ear that could interfere with delivering RAVANS&#xD;
             (e.g., wound, infection, malignancy, hypoesthesia);&#xD;
&#xD;
          -  Significant pre-existing disability of stroke-affected UL in activities of daily&#xD;
             living due to prior stroke or other medical cause defined by Stroke Impact Scale item&#xD;
             7 (SIS-hand) mean score &lt; 4 (scale: 0-5);&#xD;
&#xD;
          -  History of seizure during year before stroke or &gt; 1 post-stroke seizure;&#xD;
&#xD;
          -  Significant cognitive or language impairment that would interfere with informed&#xD;
             consent or study participation;&#xD;
&#xD;
          -  Severe dysphagia;&#xD;
&#xD;
          -  Bradycardia defined as resting heart rate &lt; 50 bpm;&#xD;
&#xD;
          -  Nonsustained ventricular tachycardia;&#xD;
&#xD;
          -  Cardiac conduction disorder (i.e., bundle branch block, heart block, long Q-T&#xD;
             syndrome);&#xD;
&#xD;
          -  History of asystole;&#xD;
&#xD;
          -  History of recurrent vaso-vagal syncope;&#xD;
&#xD;
          -  Hypotension defined as blood pressure &lt; 90/60 mmHg.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Spaulding Rehabilitation Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02129</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 20, 2017</study_first_submitted>
  <study_first_submitted_qc>September 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2017</study_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Judith Schaechter</investigator_full_name>
    <investigator_title>Assistant Professor, Department of Radiology, Harvard Medical School</investigator_title>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>vagus nerve stimulation</keyword>
  <keyword>upper extremity paresis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Weakness</mesh_term>
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Paresis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

